Evidence map›Paper›PMID 36364811›Full record

ArticleNutrients2022

Gil Zandani, Sarit Anavi-Cohen, Tamar Yudelevich, Abraham Nyska, Nativ Dudai, Zecharia Madar, Jonathan Gorelick

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Frontiers in medicine · 2026
    Article
  2. Dietary Interventions withFoods (Basel, Switzerland) · 2025
    Article
  3. The GenusPlants (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Article
  6. Molecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gil ZandaniThe Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 7670110, Israel.
Sarit Anavi-CohenSchool of Nutritional Sciences, Peres Academic Center, Rehovot 7610202, Israel.
Tamar YudelevichThe Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 7670110, Israel.
Abraham NyskaSackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Nativ DudaiUnit of Medicinal and Aromatic Plants, Newe Ya'ar Research Center, Agricultural Research Organization, Ramat Yishay 30095, Israel.
Zecharia MadarThe Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 7670110, Israel.
Jonathan GorelickEastern Regional R&D Center, Kiryat Arba 90100, Israel.

Funding

Ministry of Agriculture and Rural Development 31-37-0002
6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) has become an epidemic with increasing prevalence. Limited treatment options and poor adherence emphasize the urgent need for novel therapies for the treatment and/or prevention of NAFLD. Bioactive natural compounds found in medicinal plants are promising as novel therapeutic agents for NAFLD.

Indexed as

AsteraceaeNon-alcoholic Fatty Liver DiseasePlants, MedicinalAnimalsDiet, High-FatDisease Models, AnimalGlucoseLipid MetabolismLipidsLiverMiceMice, Inbred C57BLWeight GainGlucoseLipidsChiliadenus iphionoidesglucose tolerancelipid metabolismNAFLD

Identifiers

PMID36364811
PMCPMC9657349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.